Financial News
Press Releases about Pear Therapeutics, Inc. - Class A Common Stock
![](https://mms.businesswire.com/media/20220616005155/en/754943/5/Logo-Pear-Therapeutics-Final.jpg)
![](https://mms.businesswire.com/media/20220615005306/en/754943/5/Logo-Pear-Therapeutics-Final.jpg)
Pear Therapeutics Announces Three New Board Members
June 15, 2022
Via Business Wire
![](https://mms.businesswire.com/media/20220614005478/en/754943/5/Logo-Pear-Therapeutics-Final.jpg)
![](https://mms.businesswire.com/media/20220608005412/en/754943/5/Logo-Pear-Therapeutics-Final.jpg)
![](https://mms.businesswire.com/media/20220606005657/en/754943/5/Logo-Pear-Therapeutics-Final.jpg)
![](https://mms.businesswire.com/media/20220602005569/en/754943/5/Logo-Pear-Therapeutics-Final.jpg)
![](https://mms.businesswire.com/media/20220524005519/en/754943/5/Logo-Pear-Therapeutics-Final.jpg)
![](https://mms.businesswire.com/media/20220519005236/en/754943/5/Logo-Pear-Therapeutics-Final.jpg)
![](https://mms.businesswire.com/media/20220516005796/en/754943/5/Logo-Pear-Therapeutics-Final.jpg)
![](https://mms.businesswire.com/media/20220512005113/en/754943/5/Logo-Pear-Therapeutics-Final.jpg)
![](https://mms.businesswire.com/media/20220511005379/en/754943/5/Logo-Pear-Therapeutics-Final.jpg)
![](https://mms.businesswire.com/media/20220503005510/en/754943/5/Logo-Pear-Therapeutics-Final.jpg)
![](https://mms.businesswire.com/media/20220502005754/en/754943/5/Logo-Pear-Therapeutics-Final.jpg)
![](https://mms.businesswire.com/media/20220418005219/en/754943/5/Logo-Pear-Therapeutics-Final.jpg)
Via Business Wire
![](https://mms.businesswire.com/media/20220413005142/en/754943/5/Logo-Pear-Therapeutics-Final.jpg)
![](https://mms.businesswire.com/media/20220405005234/en/754943/5/Logo-Pear-Therapeutics-Final.jpg)
Via Business Wire
![](https://mms.businesswire.com/media/20220404005347/en/754943/5/Logo-Pear-Therapeutics-Final.jpg)
![](https://mms.businesswire.com/media/20220331005232/en/754943/5/Logo-Pear-Therapeutics-Final.jpg)
![](https://mms.businesswire.com/media/20220328005796/en/754943/5/Logo-Pear-Therapeutics-Final.jpg)
![](https://mms.businesswire.com/media/20220324005220/en/754943/5/Logo-Pear-Therapeutics-Final.jpg)
![](https://mms.businesswire.com/media/20220321005381/en/754943/5/Logo-Pear-Therapeutics-Final.jpg)
![](https://mms.businesswire.com/media/20220315005353/en/754943/5/Logo-Pear-Therapeutics-Final.jpg)
![](https://mms.businesswire.com/media/20220314005619/en/754943/5/Logo-Pear-Therapeutics-Final.jpg)
![](https://mms.businesswire.com/media/20220224005355/en/754943/5/Logo-Pear-Therapeutics-Final.jpg)
![](https://mms.businesswire.com/media/20220217005176/en/754943/5/Logo-Pear-Therapeutics-Final.jpg)
Via Business Wire
![](https://mms.businesswire.com/media/20220215005544/en/754943/5/Logo-Pear-Therapeutics-Final.jpg)
Via Business Wire
![](https://mms.businesswire.com/media/20220210005334/en/754943/5/Logo-Pear-Therapeutics-Final.jpg)
![](https://mms.businesswire.com/media/20220202005241/en/754943/5/Logo-Pear-Therapeutics-Final.jpg)
![](https://mms.businesswire.com/media/20220126005202/en/754943/5/Logo-Pear-Therapeutics-Final.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.